Financials
- Market Capitalization 11.38 B
- Employee 3 000
- Founded 1976
- CEO Kim Kelderman
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
60.91
ratio cours/chiffre d'affaires
9.13
Dividende par action
0.32
Rendement du dividende (%)
0.45
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 752 | BBIO BridgeBio Pharma, Inc. - Common Stock | 65.75 USD | +0.61% | -3.17% | -9.37% | +15.35% | 12.85 B USD | ||
| 770 | HALO Halozyme Therapeutics, Inc. - Common Stock | 111.08 USD | +0.60% | +2.03% | +2.85% | +66.29% | 12.61 B USD | ||
| 848 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 467.16 USD | -0.97% | -6.02% | -13.49% | +10.28% | 10.79 B USD | ||
| 851 | IBRX ImmunityBio, Inc. - Common Stock | 10.12 USD | -3.71% | -1.27% | +28.26% | +316.46% | 10.73 B USD |